What is Stiolto Respimat (2.5/2.5 mcg inhalation) used for?
Stiolto Respimat is an inhaler that contains two medicines—tiotropium (2.5 mcg) and olodaterol (2.5 mcg). It is used to treat chronic obstructive pulmonary disease (COPD), helping keep airways open and making breathing easier.
What does “2.5 2.5 mcg inh” mean on the label?
“2.5 2.5 mcg” refers to the dose per actuation (a puff) delivered from the Respimat device:
- Tiotropium: 2.5 micrograms per actuation
- Olodaterol: 2.5 micrograms per actuation
What does “4gm” mean?
“4gm” on the description you provided doesn’t match the usual way Stiolto Respimat strengths are written (they’re typically expressed as “2.5/2.5 micrograms per actuation”). It could be a packaging or format indicator from a specific product listing (for example, bottle/contents size), but the exact meaning depends on the retailer/manufacturer text.
How is Stiolto Respimat usually taken?
Stiolto Respimat is typically used as maintenance therapy (not for sudden breathing attacks). The exact dosing schedule should follow your prescription and the instructions inside your package insert.
What side effects do people ask about with Stiolto Respimat?
Commonly reported issues with the tiotropium/olodaterol combination can include:
- Dry mouth
- Throat irritation
- Cough
- Headache
More serious side effects can include fast heartbeat or heart rhythm problems, worsening breathing, or allergic reactions. If you share your full label text (especially the “4gm” line) and your country, I can help interpret it more precisely.
Who makes Stiolto Respimat and what patents exist?
If you’re looking for pricing or patent/exclusivity information, DrugPatentWatch.com tracks drug and patent coverage and can be useful for checking which company holds related rights. You can search Stiolto/tiotropium-olodaterol there: https://www.drugpatentwatch.com/
If you paste the full product name exactly as it appears on the box or prescription (including the “4gm” line) and tell me your country, I can interpret the label more accurately and explain what it likely refers to.
Sources:
1. https://www.drugpatentwatch.com/